Attana AB | Stockholm is a leading brand in the field of molecular interaction characterization. Established in 2002, the company is committed to understanding molecular interactions precisely as they occur in the human body. With headquarters in Stockholm, Sweden, and a research lab in London, UK, Attana develops and sells proprietary label-free biosensor instruments for biochemical, crude, sera, and cell-based assays.

The company also offers the Attana Virus Analytics (AVA) platform, a proprietary in-vitro diagnostics (IVD) tool. Attana's instruments are optimized for real-time analysis of crude samples and serum, providing biologically relevant information for accurate diagnostics and enhanced efficiency in pharmaceutical drug development. Their instruments excel in determining specificity, kinetics, affinity, and other binding characteristics of biomolecules and macrostructures.

Attana serves Big Pharma, biotech companies, and academic institutions in the life science sector. Their highly skilled application specialists also conduct contract research. Attana's proven reliability and versatility have led to their collaboration in COVID-19 vaccine and therapeutics development.

They have recently launched the Attana Virus Analytics (AVA) platform and are involved in cross-disciplinary development of a diagnostic device combining proprietary technology with AI-enabled analytics